第六屆疫苗中國(guó)發(fā)展國(guó)際峰會(huì)是2016年中國(guó)最大的疫苗行業(yè)國(guó)際峰會(huì)，幾乎涵蓋了整個(gè)疫苗產(chǎn)業(yè)鏈上的所有參與者。在此，我們將邀請(qǐng)超過(guò)300位國(guó)內(nèi)外人用疫苗及獸用疫苗領(lǐng)域的頂級(jí)專家、學(xué)者、企業(yè)高管等行業(yè)領(lǐng)袖共同探討人用及獸用疫苗行業(yè)的最新發(fā)展趨勢(shì)，研發(fā)熱點(diǎn)，合作模式，生產(chǎn)技術(shù)、市場(chǎng)及商業(yè)化策略等熱點(diǎn)話題。同時(shí)我們將為國(guó)內(nèi)外企業(yè)之間、產(chǎn)業(yè)界及學(xué)術(shù)界之間搭建學(xué)習(xí)、合作、交流的平臺(tái)，從而推動(dòng)中國(guó)及新興市場(chǎng)疫苗產(chǎn)業(yè)的快速、健康發(fā)展。
主辦單位：上海士研廣告?zhèn)髅接邢薰?/p>
支持單位：
臺(tái)灣生物產(chǎn)業(yè)發(fā)展協(xié)會(huì)
臺(tái)灣生物產(chǎn)業(yè)發(fā)展協(xié)會(huì)(Taiwan Bio Industry Organization)成立于1989年，為臺(tái)灣歷史最優(yōu)久且涵蓋最多產(chǎn)業(yè)及學(xué)術(shù)代表的生技專業(yè)團(tuán)體，本會(huì)會(huì)員包含許多根基穩(wěn)固的資深廠商、新興生技公司、學(xué)術(shù)研究機(jī)構(gòu)及政府單位代表等，本會(huì)以聯(lián)系并結(jié)合產(chǎn)業(yè)界及各學(xué)術(shù)部門，共同推動(dòng)生物科技產(chǎn)業(yè)，以發(fā)展我國(guó)經(jīng)濟(jì)及提高全民生活質(zhì)量為宗旨。
本協(xié)會(huì)每年除了舉辦各項(xiàng)研討會(huì)、訓(xùn)練課程及產(chǎn)業(yè)交流等活動(dòng)，其中最主要的就是主辦臺(tái)灣生技月(BioTaiwan)活動(dòng)—包含生物科技大展、亞洲生技商機(jī)高峰論壇、商機(jī)媒合會(huì)、兩岸生醫(yī)產(chǎn)業(yè)合作研討會(huì)等活動(dòng)，在產(chǎn)官學(xué)各方的努力經(jīng)營(yíng)之下，本活動(dòng)已成為亞太地區(qū)規(guī)模最大、吸引最多國(guó)際專業(yè)人士參與的生技活動(dòng)之一。
中國(guó)生物技術(shù)集團(tuán)
中國(guó)生物技術(shù)股份有限公司（中生股份）是中國(guó)最大的生物制藥企業(yè)。研發(fā)、生產(chǎn)并銷售用于疾病預(yù)防、治療和診斷的一系列生物醫(yī)藥制品。中生股份是中國(guó)最大的人用疫苗生產(chǎn)廠家，和中國(guó)最大的血液制品生產(chǎn)廠家，供應(yīng)中國(guó)國(guó)內(nèi)41個(gè)疫苗品種中的35種。作為中國(guó)生物制藥行業(yè)的領(lǐng)先企業(yè)，中生股份成功研發(fā)上市了一系列行業(yè)領(lǐng)先生物醫(yī)藥產(chǎn)品。
國(guó)際疫苗學(xué)會(huì)
International Society for Vaccines is an organization that engages, supports and sustains the professional goals of a diverse membership in all areas relevant to vaccines. With the successful conclusion of the 2013 Vaccine and ISV Annual Congress and ISV General Meeting, a new set of elected officials to the Executive Board will guide the Society for the next two years. Goals are focused on expanding the membership database and the enhanced attendance at the Annual Congresses. In addition, an out research initiative has begun to partner with organizations to promote ISV activities, such as VacChina 2014.
國(guó)際疫苗研究所
The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Its mission is to discover, develop, and deliver safe, effective and affordable vaccines for developing nations. Established in 1997 at the initiative of the United Nations Development Program (UNDP), IVI operates as an independent nonprofit organization under a treaty signed by 35 countries and the World Health Organization (WHO). The Institute conducts research in more than 20 countries of Asia, Africa and Latin America on vaccines primarily against enteric and diarrheal infections, Japanese encephalitis, and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea, its host country. For more information, please visit www.ivi.int.